Position in DHR
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$450,485
-$40,768 QoQ
Shares Held
2,365
-8.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#322
of 543 holders
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Wellspring Financial Advisors, LLC holds $38,813,244 across 6 Diagnostics & Research names. DHR ranks #3 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SHC |
Sotera Health Co
|
2,061,790 | $36,596,772 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
1,951 | $978,153 | |
| 3 | DHR |
Danaher Corp /De/
This page
|
2,365 | $450,485 | |
| 4 | LH |
Labcorp Holdings Inc.
|
1,049 | $293,720 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
502 | $264,272 | |
| 6 | MEDP |
Medpace Holdings, Inc.
|
434 | $229,842 |
All Filings in DHR
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $450,485 | 2,365 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $491,253 | 2,591 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $805,111 | 3,517 | Shares | Sole | 2026-02-11 | |
| 2025-06-30 | $246,727 | 1,249 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $342,760 | 1,672 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $408,139 | 1,778 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $599,133 | 2,155 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $422,996 | 1,693 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $363,842 | 1,457 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $330,353 | 1,428 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $270,314 | 1,229 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||